Pharmaceutical Logistics Market to Reach US$ 247.8 Billion by 2033 at 9.8% CAGR; North America Leads with 38% Share | Key Players FedEx, DHL, CEVA

The pharmaceutical logistics market reached approximately US$ 114.5 billion in 2024 and is expected to reach around US$ 247.8 billion by 2033, growing at a CAGR of about 9.8% during the forecast period 2025-2033. Market growth is driven by rising demand for temperature-controlled transportation, increasing global pharmaceutical trade, expanding biologics and vaccine shipments, and stringent regulatory requirements for drug safety and traceability. Adoption of digital supply chain solutions including IoT tracking, blockchain for serialization, and advanced cold chain technologies is enhancing shipment visibility, compliance, and product integrity, further supporting market expansion.

North America held the largest market share due to a well-established healthcare supply chain, high pharmaceutical manufacturing output, and strong regulatory enforcement for quality logistics practices. Europe follows with robust cold chain infrastructure and increasing emphasis on serialization and track-and-trace systems. Asia-Pacific is expected to witness the fastest growth driven by expanding pharmaceutical production hubs, increasing healthcare demand, rising exports of generic drugs, and growing investments in logistics infrastructure across emerging economies.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/pharmaceutical-logistics-Market?sai-v

The pharmaceutical logistics market refers to the global industry focused on the storage, handling, and transportation of pharmaceutical products while ensuring quality, safety, and regulatory compliance.

Key Developments
✅ January 2026: In North America, logistics providers expanded temperature-controlled logistics networks for biologics, vaccines, and advanced therapies by deploying next-generation cold chain solutions, led by UPS Healthcare, FedEx Supply Chain, and DHL Life Sciences & Healthcare, improving shipment integrity and regulatory compliance.

✅ January 2026: In Europe, adoption of digital freight platforms and IoT-enabled real-time tracking increased among pharmaceutical manufacturers and distributors, supported by solutions from Kuehne + Nagel, DB Schenker, and CEVA Logistics to enhance visibility and quality assurance.

✅ December 2025: In Asia-Pacific, investment in pharma-grade distribution hubs and automated fulfillment centers accelerated to support rising biologics and vaccine volumes, with expansions by DHL, Yusen Logistics, and Nippon Express strengthening regional supply chains.

✅ December 2025: Globally, deployment of blockchain-enabled serialization and traceability platforms improved anti-counterfeiting and end-to-end transparency, with technology adoption involving SAP, Oracle, and IBM.

✅ November 2025: In Latin America, partnerships between global logistics specialists and regional healthcare distributors expanded cold chain infrastructure, supported by AmerisourceBergen, Cardinal Health, and GEFCO, improving access to temperature-sensitive medicines.

✅ October 2025: Worldwide, use of AI-driven demand forecasting and route optimization technologies increased to reduce spoilage risk and improve delivery efficiency, driven by solutions from Blue Yonder, Manhattan Associates, and Logility.

Mergers & Acquisitions
✅ January 2026: In the United States, FedEx Supply Chain acquired a specialized cold chain logistics provider to expand its pharmaceutical and biologics transportation capabilities.

✅ December 2025: In Europe, Kuehne + Nagel completed the acquisition of a regional pharmaceutical logistics company with advanced temperature-controlled warehousing to strengthen its life sciences operations.

✅ November 2025: In Asia-Pacific, Yusen Logistics acquired a healthcare fulfillment and distribution firm to enhance its end-to-end pharmaceutical logistics service offerings.

Key Players
AIT Worldwide Logistics, Inc. | Yusen Logistics | Air Canada Cargo | CEVA Logistics SA | Continental Carriers Pvt Ltd | Deutsche Post AG | FedEx Corporation | Kerry Logistics Network Limited | AWL | Nippon Express Holdings | Others

Key Highlights
FedEx Corporation holds 22% share, driven by its extensive global air cargo network, advanced tracking infrastructure, and strong presence in time-critical and express logistics services.

Deutsche Post AG holds 19% share, supported by its DHL Global Forwarding division, integrated end-to-end logistics solutions, and strong international freight capabilities.

CEVA Logistics SA holds 12% share, leveraging multimodal logistics expertise, contract logistics strength, and strong relationships with industrial and automotive clients.

Nippon Express Holdings holds 11% share, driven by its dominance in Asia-Pacific logistics, air-sea freight integration, and cross-border trade solutions.

Yusen Logistics holds 9% share, supported by its strong automotive and industrial logistics portfolio and global freight forwarding operations.

Kerry Logistics Network Limited holds 8% share, benefiting from its Asia-focused network, e-commerce logistics capabilities, and growing international footprint.

AIT Worldwide Logistics, Inc. holds 7% share, driven by customized freight solutions, strength in aerospace and life sciences logistics, and flexible supply chain services.

Air Canada Cargo holds 5% share, supported by its dedicated cargo fleet, strong North American routes, and international belly cargo capacity.

Continental Carriers Pvt Ltd holds 4% share, leveraging regional freight forwarding expertise and strong customer relationships in emerging markets.

AWL holds 3% share, focusing on specialized logistics services and niche freight solutions.

Others collectively hold 0-5% share, comprising regional logistics providers and niche air and ocean freight specialists.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-logistics-Market?sai-v

Market Drivers
- Growing global pharmaceutical manufacturing and distribution activities increasing demand for efficient logistics and supply chain solutions.

- Rising complexity of drug portfolios including biologics, specialty therapeutics, and temperature-sensitive products requiring advanced cold chain management.

- Increasing regulatory compliance requirements for serialization, traceability, and supply chain security.

- Expansion of e-commerce and direct-to-patient pharmaceutical delivery models accelerating demand for agile logistics networks.

- Adoption of digital technologies such as IoT sensors, blockchain, and AI analytics to enhance visibility and optimize pharmaceutical supply chains.

Industry Developments
- Deployment of advanced cold chain logistics solutions including real-time temperature monitoring and controlled storage systems.

- Integration of blockchain and traceability platforms to ensure secure and compliant pharmaceutical transportation.

- Expansion of third-party logistics (3PL) partnerships offering specialized pharmaceutical distribution, warehousing, and last-mile delivery services.

- Strategic investments in automated fulfillment centers, robotics, and sorting technologies to improve efficiency and reduce turnaround times.

- Growth of digital supply chain platforms leveraging predictive analytics to forecast demand and mitigate disruptions.

Regional Insights
North America - 38% share: "Driven by strong pharmaceutical manufacturing base, stringent regulatory standards, advanced cold chain infrastructure, and high adoption of digital logistics solutions."

Europe - 29% share: "Supported by harmonized regulations, robust distribution networks, advanced tracking technologies, and growing biologics logistics demand."

Asia Pacific - 23% share: "Fueled by rapid expansion of pharmaceutical production, rising healthcare demand, increasing biologics shipments, and logistics modernization initiatives."

Latin America - 6% share: "Driven by improving pharmaceutical distribution infrastructure, expanding healthcare access, and growing e-commerce adoption."

Middle East & Africa - 4% share: "Supported by investments in cold chain facilities, improving transport networks, and increasing focus on supply chain resilience."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmaceutical-logistics-Market?sai-v

Key Segments

By Service Type
Cold chain logistics account for a significant share due to the growing transportation of temperature-sensitive biologics, vaccines, and specialty pharmaceuticals requiring strict thermal control. Non-cold chain logistics continue to hold a substantial presence, supported by high volumes of conventional drugs and pharmaceutical chemicals that do not require temperature regulation.

By Mode of Transport
Air transport dominates for high-value, time-sensitive, and temperature-controlled pharmaceutical shipments, particularly in international trade. Road transport is widely used for domestic distribution owing to flexibility and last-mile connectivity. Water transport supports bulk international shipments of pharmaceutical raw materials and finished products, while rail transport is gaining attention as a cost-effective and sustainable option for long-distance inland movement.

By Pharmaceutical Product Type
Bio-pharmaceuticals represent a fast-growing segment driven by increasing biologics, vaccines, and cell- and gene-based therapies. Pharmaceutical end products account for a major share due to consistent global demand for finished dosage forms. Pharmaceutical chemicals, including APIs and intermediates, maintain steady demand linked to drug manufacturing activities, while others include medical devices, diagnostic products, and ancillary healthcare supplies.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.